High blood-pressure drug Apo-Ramipril recalled
Apotex Incorporated has issued a voluntary recall for one lot of its hypertension treatment drug Apo-Ramipril 5mg Capsules. This recall has been issued to retail businesses throughout Canada. The recall of the Apo-Ramipril 5mg Capsules in Lot JR2178 is due to the fact that the capsules are sealed and empty of any medication. Health Canada is currently informing the public of this problem, which first became apparent after a patient complained about the empty capsules. Patients being treated for hypertension taking capsules from this lot will not receive the recommended dosage of their prescribed medication, which may cause kidney problems, stroke, inadequate blood circulation, internal bleeding, heart attack or stroke. Patients who have recently experienced a heart attack or may be at risk for a heart attack or stroke may have also been prescribed Apo-Ramipril 5mg Capsules, though the drug is primarily used to treat hypertension. The medication affected in this recall are labeled with the drug identification number DIN 02252574. The capsules are not transparent, so determining whether the capsule has medication inside it can be a problem.
As a Los Angeles personal injury lawyer, I am hopeful that this medical recall has been issued in time to prevent anyone from being harmed, but all too often that is not the case.
If you or someone you love has been injured or made ill by a defective medical product, give our Product Defect Attorneys a call and book your FREE case consultation today!